Title: Interim Access Policy for Compounding Using Certain Peptides
Agency/Subagency: 0910-HHS/FDA
Stage of Rulemaking: Notice Stage
Meeting Date/Time: 10/28/2026 03:00 PM
Requestor: Faegre Drinker Consulting Requestor's Name: Josh Andrews Requestor's Client: Collaborative for Evidence-Based Medicines